Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2005 4
2006 6
2007 4
2008 3
2010 2
2011 1
2014 1
2015 5
2016 2
2017 3
2018 2
2019 3
2021 2
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction.
Polzin A, Dannenberg L, Benkhoff M, Barcik M, Helten C, Mourikis P, Ahlbrecht S, Wildeis L, Ziese J, Zikeli D, Metzen D, Hu H, Baensch L, Schröder NH, Keul P, Weske S, Wollnitzke P, Duse D, Saffak S, Cramer M, Bönner F, Müller T, Gräler MH, Zeus T, Kelm M, Levkau B. Polzin A, et al. Among authors: keul p. Nat Commun. 2023 Apr 26;14(1):2404. doi: 10.1038/s41467-023-38069-5. Nat Commun. 2023. PMID: 37100836 Free PMC article.
Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells.
Thomas N, Schröder NH, Nowak MK, Wollnitzke P, Ghaderi S, von Wnuck Lipinski K, Wille A, Deister-Jonas J, Vogt J, Gräler MH, Dannenberg L, Buschmann T, Westhoff P, Polzin A, Kelm M, Keul P, Weske S, Levkau B. Thomas N, et al. Among authors: keul p. Nat Commun. 2023 Dec 14;14(1):8329. doi: 10.1038/s41467-023-44109-x. Nat Commun. 2023. PMID: 38097610 Free PMC article.
Sphingosine-1-phosphate improves outcome of no-reflow acute myocardial infarction via sphingosine-1-phosphate receptor 1.
Polzin A, Dannenberg L, Benkhoff M, Barcik M, Keul P, Ayhan A, Weske S, Ahlbrecht S, Trojovsky K, Helten C, Haberkorn S, Flögel U, Zeus T, Müller T, Gräler MH, Kelm M, Levkau B. Polzin A, et al. Among authors: keul p. ESC Heart Fail. 2023 Feb;10(1):334-341. doi: 10.1002/ehf2.14176. Epub 2022 Oct 11. ESC Heart Fail. 2023. PMID: 36217778 Free PMC article.
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
Kohlmorgen C, Gerfer S, Feldmann K, Twarock S, Hartwig S, Lehr S, Klier M, Krüger I, Helten C, Keul P, Kahl S, Polzin A, Elvers M, Flögel U, Kelm M, Levkau B, Roden M, Fischer JW, Grandoch M. Kohlmorgen C, et al. Among authors: keul p. Diabetologia. 2021 Aug;64(8):1834-1849. doi: 10.1007/s00125-021-05498-0. Epub 2021 Jun 16. Diabetologia. 2021. PMID: 34131781 Free PMC article.
41 results